Tag: VaxNewMo

VaxNewMo is developing next generation conjugate vaccines against bacterial diseases using its patented conjugating enzyme technology. Our conjugating enzyme technology is faster, more natural, and more reliable than methods used by pharmaceutical companies.

Learn more about VaxNewMo at www.linkedin.com/company/vaxnewmo.

VaxNewMo’s Vaccine Breakthrough Published in Nature

The BioGenerator-backed startup and Arch Grant recipient gets highlighted by Nature Communications for its 'promising process' to more quickly and affordably bring vaccines to market.

A “No” from Arch Grants Isn’t a “No” to Your Business

Once you've had a chance to take advantage of St. Louis's other startup resources, talk with your mentors, and strengthen your application, you should definitely consider re-applying the following year.

Bioscience Startup Founders: Expect Bumps in the Road From Academic to Entrepreneur

Scientists entering the workforce are highly trained in their respective disciplines, but the academic world doesn't always prepare them for entrepreneurship. Two Arch Grants Recipients share how they learned to sell their science to potential investors and partners.

Meet the Next Generation of Job Creators Winning in St. Louis

St. Louis’ Innovation Community gave the region's top startups the chance to present their companies to a packed house of entrepreneurs, investors, and other members of the innovation community at the...

18 Startups Win $50,000 Each To Locate Their Business In St Louis

5th Annual Arch Grants Gala sees huge donations made to help startups relocate their companies to St Louis and make a difference.

Latest Stories

Popular Stories